论文信息 - Phase I, ﬁ rst-in-human study of futibatinib, a highly selective, irreversible FGFR1 e 4 inhibitor in patients with advanced solid tumors - 字舞流文

Phase I, ﬁ rst-in-human study of futibatinib, a highly selective, irreversible FGFR1 e 4 inhibitor in patients with advanced solid tumors

F. Meric-Bernstam | B. Tran | I. Matos | R. Bahleda | K. Benhadji | L. Goyal | Y. He | I. Yamamiya | H. Arkenau